GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bayer AG (OTCPK:BAYZF) » Definitions » Cyclically Adjusted Price-to-FCF

Bayer AG (Bayer AG) Cyclically Adjusted Price-to-FCF : 5.17 (As of May. 23, 2024)


View and export this data going back to 2009. Start your Free Trial

What is Bayer AG Cyclically Adjusted Price-to-FCF?

As of today (2024-05-23), Bayer AG's current share price is $29.73. Bayer AG's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was $5.75. Bayer AG's Cyclically Adjusted Price-to-FCF for today is 5.17.

The historical rank and industry rank for Bayer AG's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

BAYZF' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 4.78   Med: 13.84   Max: 33.49
Current: 5.4

During the past years, Bayer AG's highest Cyclically Adjusted Price-to-FCF was 33.49. The lowest was 4.78. And the median was 13.84.

BAYZF's Cyclically Adjusted Price-to-FCF is ranked better than
95.85% of 313 companies
in the Drug Manufacturers industry
Industry Median: 33.44 vs BAYZF: 5.40

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Bayer AG's adjusted free cash flow per share data for the three months ended in Mar. 2024 was $-2.872. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is $5.75 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Bayer AG Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Bayer AG's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bayer AG Cyclically Adjusted Price-to-FCF Chart

Bayer AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.47 9.52 9.29 8.77 6.12

Bayer AG Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.19 9.92 8.81 6.12 5.35

Competitive Comparison of Bayer AG's Cyclically Adjusted Price-to-FCF

For the Drug Manufacturers - General subindustry, Bayer AG's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bayer AG's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bayer AG's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Bayer AG's Cyclically Adjusted Price-to-FCF falls into.



Bayer AG Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Bayer AG's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=29.73/5.75
=5.17

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bayer AG's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Bayer AG's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-2.872/125.0381*125.0381
=-2.872

Current CPI (Mar. 2024) = 125.0381.

Bayer AG Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 1.758 99.543 2.208
201409 1.981 99.823 2.481
201412 1.928 99.543 2.422
201503 0.498 99.717 0.624
201506 1.833 100.417 2.282
201509 2.277 100.417 2.835
201512 1.265 99.717 1.586
201603 1.291 100.017 1.614
201606 1.893 100.717 2.350
201609 3.253 101.017 4.027
201612 2.189 101.217 2.704
201703 0.523 101.417 0.645
201706 2.332 102.117 2.855
201709 2.899 102.717 3.529
201712 1.805 102.617 2.199
201803 0.430 102.917 0.522
201806 2.272 104.017 2.731
201809 1.657 104.718 1.979
201812 2.137 104.217 2.564
201903 0.789 104.217 0.947
201906 1.314 105.718 1.554
201909 1.741 106.018 2.053
201912 2.463 105.818 2.910
202003 -0.697 105.718 -0.824
202006 2.097 106.618 2.459
202009 1.700 105.818 2.009
202012 -0.176 105.518 -0.209
202103 -3.749 107.518 -4.360
202106 1.844 108.486 2.125
202109 2.589 109.435 2.958
202112 2.192 110.384 2.483
202203 -1.205 113.968 -1.322
202206 1.672 115.760 1.806
202209 1.943 118.818 2.045
202212 1.873 119.345 1.962
202303 -4.377 122.402 -4.471
202306 -0.135 123.140 -0.137
202309 2.056 124.195 2.070
202312 5.118 123.773 5.170
202403 -2.872 125.038 -2.872

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Bayer AG  (OTCPK:BAYZF) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Bayer AG Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Bayer AG's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Bayer AG (Bayer AG) Business Description

Industry
Address
Kaiser-Wilhelm-Allee 1, Leverkusen, NW, DEU, 51368
Bayer is a German healthcare and agriculture conglomerate. Healthcare provides close to half of the company's sales and includes pharmaceutical drugs as well as vitamins and other consumer healthcare products. The firm also has a crop science business that includes seeds, pesticides, herbicides, and fungicides, which was expanded through the acquisition of Monsanto.